Tata Main Hospital Picks Up Ivermectin/Doxycycline Combo Regimen to Address COVID-19

Aug 9, 2020 | COVID-19, India, Ivermectin, News, Popular Posts, Tata Main Hospital

Tata Main Hospital Picks Up IvermectinDoxycycline Combo Regimen to Address COVID-19

Tata Main Hospital (TMH), established in 1908, has added the combination of Ivermectin and Doxycycline to its COVID-19 treatment protocol in addition to already adding Convalescent Plasma Therapy for the treatment of SARS-CoV-2 infected patients. The hospital has already embraced the antivirals of Remdesivir and Favipiravir under Emergency Use Authorization, which has been blessed by the Indian Council of Medical Research (ICMR).

Ivermectin Use in India

Already in use in many hospitals to address COVID-19 infections, such as Lady Hardinge Medical College, Max Hospital, Lok Nayak and others, the momentum in India is undeniable as TrialSite just reported the northern Indian state of Uttar Pradesh is embracing the antiparasitic drug as a COVID-19 regimen. 

Ivermectin Use in Bangladesh

The use of Ivermectin in northwestern neighbor Bangladesh has also showed tremendous results. Several studies involving Ivermectin and COVID-19 yield results that shouldn’t be overlooked by Western pharmaceutical sponsors suggests TrialSite News, including the work of Dr. Tarek Alam and the Bangladesh Medical College.

Tata Steel Main Hospital

Now The Pioneer in India reports that the Tata conglomerate has embraced “the Wonder Drug.” During a telephone interview Dr. Rajan Choudhry, general manager, medical services for Tata Steel reports that a total of 1,455 patients were tested positive for COVID-19 at the hospital. Most of the patients originate from East Sighbhum area. Thus far, 920 have been discharged already while the hospital reports 68 deaths. The recovery rate right now is 62.2 percent.

The existing regimens include Remdesivir and Favipiravir while they have ordered Roche’s Tocilizumab. Now, the general manager told The Pioneer that they report adding Ivermectin and Doxycycline to its COVID-19 treatment protocol.

The hospital also has the greenlight to use convalescent plasma however there have been reported shortages in India leading to not enough donations from recovered COVID-19 patients. However, as TrialSite has reported, part of the problem are the inclusion and exclusion criteria.

Hospital Description

Tata Main Hospital (TMH) has been in operation since 1908 and dedicated to serve Tata Steel employees, their families and the citizenry of Jamshedpur and peripheral locations. This hospital was the inspiration of the founders of Tata with a goal that included the health and welfare of employees.

A multi-specialty hospital that includes eight clinics across the city. With a 914 bed hospital, the provider employs about 2,000, including 300 doctors and 695 nurses and 150 paramedics, technicians and pharmacists.

The hospital reports a robust quality system including ISO 9001:2008 accredited certification since 2010. It has received NABL accreditation for being the first hospital based pathology Lab and Progressive level NABH accreditation.

Tata Main Hospital includes a Research arm as well that has a significant focus on malaria and other tropical disease

Source: DailyPioneer

5 Comments

  1. Arun Kumar Laha

    COVID19 and Ivermectin

    High population density plus unlocking lead to community transmission, resulting in fast increase in the number of COVID19 cases in India. Good news is that, large number of infected persons would be cured of the disease without much symptoms; these asymptomatic persons would not subject themselves to any form of testing or treatment; they would roam freely in society and would infect more persons – and this would usher in HERD IMMUNITY in India.

    Patients with mild-to-moderate symptoms do not require costly indoor treatment; and such patients should be treated by doctors at the periphery; and the doctors should treat these patients based on clinical assessments of the patients – elaborate testing, to exclude COVID19, for each and every persons suffering from fever with mild-to-moderate Flu-like symptoms is a very costly proposition. There would be severe forms of chaos if we try to cater indoor treatment to all symptomatic patients presenting with mild-to-moderate Flu-like features. However, severely ill patients, aged patients with comorbidities should be admitted in well-equipped institutions.

    ICMR should allow doctors, not attached to any state-run hospital or private institution, to treat patients with mild-to-moderate Flu-like symptoms with a cocktail of drugs – Vitamin D, Vitamin C, Zinc, Azithromycin and Ivermectin. Doctors attached to state-run or private institutions are, I think, already instructed by ICMR about management of such patients at indoor and outdoor.

    COVID19 is a Global emergency; we do not have much time for elaborate clinical trials (multi-centric, double-blind, placebo-controlled, above all, reports should be acceptable to peer-group-reviewed international Journals) to prove or disprove efficacy of Ivermectin in treating COVID19. Doctors of many nations have published reports proving excellent efficacy of Ivermectin; no doubt, these studies have been conducted with a small number of patients; but still, we cannot discard the inferences of these reports out right, because these findings are collected by senior physicians with long experiences in clinical medicine.

    Arun Kumar Laha 09 06 2020

    IVERMECTIN

    Times Of India published two reports on 21st and 22th May praising Rendesivir and Favipiravir, two antivirals. Mainstream media worldwide are promoting these drugs of big pharma companies; however, most, if not all, antivirals are of questionable efficacy. No one is promoting IVERMECTIN, a cheap oral drug, prescribing which against COVID19 doctors from many nations, including Bangladesh, got EXCELLENT results. No one is interested in promoting this off patented molecule. Scientists could not fabricate vaccines against all and every pathogenic Virus; most probably, COVID19 is one of such type. Monoclonal antibody against viral proteins, however, is a good treatment plan.

    NO MASK, NO SOCIAL DISTANCING, NO LOCKDOWN, WILL BE ABLE TO SAVE HUMANITY FROM COVID19. IVERMECTIN, HCQ AND HERD IMMUNITY DUE TO SUBCLINICAL INFECTION IN COMMUNITY AT LARGE WOULD SAVE US.

    Fight against COVID19

    To fight against COVID19 India has to chalk out her own plan; we should not ape other nations. There would be serious socio-economic disaster in India if we continue total or partial lockdown. Most of the COVID19 infected patients in India are asymptomatic; and this might be due to the presence of Curcumin in our daily food. So, it is very difficult to determine patient- load in India; we can not test for COVID19 in all persons under the Sun.

    Asymptomatic persons would refuse testing and any form of treatment – they would roam freely in society; and would infect the population at large; and this will in near future usher in HERD IMMUNITY in India. Most of the symptomatic patients present with mild to moderate illness; we should treat them as OPD patients. We have to treat these patients with mild-to-moderate Flu-like symptoms as quickly as possible; so that they do not become severely ill to overwhelm the scarce indoor facilities in our country. Here is a safe outdoor treatment plan that will show quick and effective response in symptomatic patients (for adults): – Vitamin D & C and Zinc daily in usual recommended doses + Virostatic drug Ivermectin 12mg daily for 3 to 5 days + Senolytic antibiotic Azithromycin 250mg to 500mg daily for 5 days to 10 days. This treatment plan ushers in prompt response. Serious indoor patients would get these medicines + necessary supportive measures + Hydroxychloroquine (HCQS). – Arun Kumar Laha 29, Abinash Banerjee Lane. Howrah 711104. (laha.a53@gmail.com)

    Disclaimer: –

    This is not a prescription for the general public to self- medicate themselves. It is for the medical fraternity to think about my humble suggestion.

    To solve the problems of COVID 19, lockdown is not the only way out; we have to rely on development of HERD IMMUNITY by exposing people to low grade infection with COVID19 and we have to treat the symptomatic patients as fast as possible, to cut short the number of serious patients requiring indoor treatment.

    Many health- care personnel and other fighters against COVID19 are losing their lives to save humanity at large; ICMR should think about prescribing IVERMECTIN (12mg in empty stomach once in a week instead of Hydroxychloroquine) to these persons. Ivermectin is safer than Hydroxychloroquine.

    Clinical trials with IVERMECTIN

    To treat Covid19, Ivermectin should be given orally in empty stomach – 200mcg to 600mcg per Kg body weight daily for 3 to 5 days; and Azithromycin 250mg to 500mg orally in empty stomach for 10 days. This is the best treatment plan for Covid19 patients with mild-to-moderate symptoms. To prevent Covid19 one should take only Ivermectin in empty stomach 200mcg per Kg body weight once in a week. Clinical trials with inadequate doses of Ivermectin do not give desired results; and anti-Ivermectin lobbies would start shouting that, Ivermectin is worthless in treating and preventing Covid19.

  2. Arun Kumar Laha

    In the last many millennia the human race suffered from frequent devastating epidemics of Smallpox, a highly contagious viral disease. God expressed Himself as intelligence in a British clinician, who discovered that, prior infection with milder Cowpox protects a person from inflicting deadly Smallpox. This observation leads to development of a highly effective vaccine against Smallpox; and thank God, Smallpox has now been completely eradicated from the human race.

    At one time epidemics of Great Pox or Large Pox (Secondary Syphilis), a difficult to treat bacterial infection, were very common in many parts of the Globe. Clinicians worldwide tried many treatment plans to cure this life threatening disease; but failed miserably. God sprinkled some Fungus in the Petri Dishes of bacterial culture at the laboratory of an observant British Pathologist – Penicillin was discovered; and Penicillin was proved to be the best treatment for Syphilis. Now-a-days Great Pox is no longer seen.

    In April this year (2020) God expressed Himself as intelligence in some Australian scientists to conduct an in vitro study with Ivermectin, a drug known for many years, against Covid19. It was a great success. Ivermectin has surfaced as the best and the safest drug against Covid19.

    Ivermectin is a unique gift of God to rescue the human race facing, in the last few months, the worst form of all round devastation; unlike Covid19, no previous problem on the Earth has affected each and every person of all nations.

    Arun Kumar Laha MD., Dip. Card.

    09 08 2020

    • Dr. Mouli

      Sir
      Excellent write up. We should not concentrate on so many phases of clinical trails. We must get Vaccine as soon as possible. If vaccine is not safe it will show in first phase it self.

  3. Einas Alfwal

    Many thanks

  4. Suresh

    Thank you for the very informative post.

    Please provide an update on additional learning about ivermectin effectiveness in patients you have come across in last few days. If the treatment is effective it would benefit many to publish your learnings in a peer reviewed journal as well. Knowledge is better spread by such publications.